There are also evidences that miR-27 could facilitate the epithelial-mesenchymal transition (EMT) and the endothelial-mesenchymal transition (EndMT) in several types of cancer, including colorectal cancer through the activation of the transforming growth factor-β (TGF-β) [34,35]. This evidence concerns the gene TGFB1 and colorectal cancer.